Davis Vision is offering a new vision plan, idealChoice, which features increased access, an expanded offering of frames and a wider variety of lens options. Under this plan, members will have access to more independent providers than any other Davis V…
Author: OphthalmologyWeb
Physicians Must Protect Themselves From Increased Prosecution Under Health Care Reform Legislation
Ophthalmologists must prepare themselves and their practices for what could be surprising effects of recent changes to health care legislation, according to an attorney speaking here.
Physicians Must Protect Themselves From Increased Prosecution Under Health Care Reform Legislation
Ophthalmologists must prepare themselves and their practices for what could be surprising effects of recent changes to health care legislation, according to an attorney speaking here.
New Accommodating IOL Technologies Set To Expand Presbyopia-Correction Options
In addition to currently available accommodating IOLs on the U.S. market, there are a number of new accommodating IOL technologies awaiting approval or in development that will improve presbyopia-correcting options, according to a speaker here.
Webinar – RTVue 100 Fourier-Domain OCT: Clinical uses of the RTVue OCT for Anterior Segment
Featured Article
CooperVision Announces Roll-Out Of Avaira® Toric Contact Lenses
CooperVision today announced the national rollout of Avaira® Toric silicone hydrogel lenses for astigmatic patients in the United States. Avaira Toric was launched in June, but demand was so high for this lens, the launch was restricted to a few thous…
Physicians Must Protect Themselves From Increased Prosecution Under Health Care Reform Legislation
Ophthalmologists must prepare themselves and their practices for what could be surprising effects of recent changes to health care legislation, according to an attorney speaking here.
Physicians Must Protect Themselves From Increased Prosecution Under Health Care Reform Legislation
Ophthalmologists must prepare themselves and their practices for what could be surprising effects of recent changes to health care legislation, according to an attorney speaking here.
New Accommodating IOL Technologies Set To Expand Presbyopia-Correction Options
In addition to currently available accommodating IOLs on the U.S. market, there are a number of new accommodating IOL technologies awaiting approval or in development that will improve presbyopia-correcting options, according to a speaker here.
Physicians Must Protect Themselves From Increased Prosecution Under Health Care Reform Legislation
Ophthalmologists must prepare themselves and their practices for what could be surprising effects of recent changes to health care legislation, according to an attorney speaking here.
Corneal Hydrops Secondary To Keratoconus Linked With Mitral Valve Prolapse
Corneal hydrops secondary to keratoconus correlated strongly with mitral valve prolapse, a study found.
Corneal Collagen Cross-Linking Improves Long-Term VA In Treating Keratoconus, Ectasia
Corneal collagen cross-linking markedly improved visual acuity in patients with keratoconus or corneal ectasia, a study found.
Enzyme Inhibition Or Removal May Prevent Or Treat Ischemic Retinopathy
The inhibition or removal of an enzyme may prevent or treat ischemic retinopathy by stalling growth of unwanted vessels in the retina, Medical College of Georgia researchers say.
Enzyme Inhibition Or Removal May Prevent Or Treat Ischemic Retinopathy
The inhibition or removal of an enzyme may prevent or treat ischemic retinopathy by stalling growth of unwanted vessels in the retina, Medical College of Georgia researchers say.
New Year, New Vision, New Health
VISTAKON®, Division of Johnson & Johnson Vision Care, Inc., and makers of ACUVUE® Brand Contact Lenses today announced the “New You” sweepstakes to give consumers the chance to have improved vision and better fitness in the New Year.
InSite Vision Files IND For ISV-101 With The U.S. Food And Drug Administration For The Treatment Of Dry Eye Disease
InSite Vision Incorporated (OTCBB:INSV) announced that it has filed an Investigational New Drug (IND) application for ISV-101 with the U.S. Food and Drug Administration (FDA). ISV-101 is InSite Vision’s novel compound being developed to treat dry eye d…
AMD Prevalence Among US Adults Drops In Past 20 Years
The prevalence of age-related macular degeneration in adults aged 40 years and older in the United States declined 30.8% in the last 2 decades, a large national study found.
Scientific Evidence Supports Effectiveness Of Chinese Drug For Cataracts
Scientists are reporting a scientific basis for the long-standing belief that a widely used non-prescription drug in China and certain other countries can prevent and treat cataracts, a clouding of the lens of the eye that is a leading cause of vision …
InSite Vision Files IND For ISV-101 With The U.S. Food And Drug Administration For The Treatment Of Dry Eye Disease
InSite Vision Incorporated (OTCBB:INSV) announced that it has filed an Investigational New Drug (IND) application for ISV-101 with the U.S. Food and Drug Administration (FDA). ISV-101 is InSite Vision’s novel compound being developed to treat dry eye d…
AMD Prevalence Among US Adults Drops In Past 20 Years
The prevalence of age-related macular degeneration in adults aged 40 years and older in the United States declined 30.8% in the last 2 decades, a large national study found.